Notably, the strong inhibitor, RNA S1, mitigates aberrant FUS phase behavior in neurons and enhances the survival of disease neurons harboring ALS-causing FUS mutation30, underscoring therapeutic potential. This evidence concerns the gene FUS and amyotrophic lateral sclerosis.